Sunshine Biopharma Inc.
SBFM | NASDAQ
$0.91
+$0.01 (+1.13%)
At close: Sep 21, 2026, 4:00 PM ET
$0.97
+$0.06 (+6.24%)
Pre-market:
Sep 22, 2026, 4:16 AM ET
Market Data
Market Cap $2.14M
Enterprise Value $-11.59M
Beta 1.32
Average Volume 1.66M
Shares Outstanding (Diluted) 1.37M
Shares Change YoY 5973.24%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US8677818093
Price Performance
Price Change 1M -20.9%
Price Change 3M -55.4%
Price Change 6M -91.2%
Price Change YTD -92.9%
Price Change 1Y -94.0%
Price Change 3Y -100.0%
Price Change 5Y -100.0%
1M CAGR (ann.) -35.7%
1Y CAGR (ann.) -93.9%
5Y CAGR (ann.) -90.4%
All-Time CAGR -69.3%
Valuation
PE Ratio -0.09
Forward PE 33.18
PEG Ratio -0.00
Forward PEG 0.00
PS Ratio 0.06
Forward PS 0.00
PB Ratio 0.08
P/FCF Ratio -0.47
P/Adj. FCF Ratio -0.47
P/OCF Ratio -0.23
EV/Sales -0.33
EV/EBIT 2.07
EV/EBITDA 2.20
EV/FCF 2.52
Earnings Yield -1115.4%
FCF Yield -212.7%
Adj. FCF Yield -212.7%
Financial Health
Net Cash $13.75M
Total Debt $0
Cash & Short-Term Investments $13.75M
Total Assets $2.97M
Current Ratio 5.46
Quick Ratio 3.30
Debt / Equity Ratio 0.02
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -18.22
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 29.8%
Operating Profit Margin -14.7%
EBITDA Margin -14.9%
Net Profit Margin -16.5%
FCF Margin -13.0%
Adj. FCF Margin -13.0%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets -17.3%
Return on Equity -24.2%
Return on Invested Capital -18.4%
Return on Capital Employed -18.6%
Return on Tangible Assets -18.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 34.5%
Revenue CAGR 5Y 203.1%
Revenue CAGR 10Y 39.6%
EPS CAGR 3Y 141.7%
EPS CAGR 5Y 91.0%
EPS CAGR 10Y 52.0%
FCF CAGR 3Y 41.7%
FCF CAGR 5Y -4.5%
FCF CAGR 10Y -27.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $7
Price Target Upside 669.2%
Cash Flow
Operating Cash Flow $-5.33M
Free Cash Flow $-4.6M
Adj. Free Cash Flow $-4.6M
FCF Per Share -$3.37
OCF Per Share -$3.91
OCF/S Ratio -15.1%
Income Statement
Revenue $35.35M
Gross Profit $10.53M
Operating Income $-5.2M
EBITDA $-5.26M
Net Income $-5.83M
EPS (Diluted) -$10.15
Revenue / Employee $706.94K
Profit / Employee $-116.65K
Employees 50
Add to Watchlist
Select watchlists to add or remove SBFM